Mid-size biotech Target potential upsell opportunities around advanced chromatography and analytical systems, emphasizing broader deployment across research and practice settings given their focus on gas chromatography, liquid chromatography, HPLC, SFE, and SFC.

Expansion readiness Position as a supplier for scalable instrumentation and consumables to support growth as they operate with a modest to mid-range employee base and revenue, aligning with potential procurement cycles in expanding labs.

Cost effective growth Highlight cost-efficient, value-driven product bundles and service plans to fit a company with $25M–$50M revenue, aiming at total cost of ownership reductions and maintenance optimization.

Competitive differentiation Differentiate with specialized niche capabilities in chromatography and flow injection analysis, offering tailored training, support, and regulatory-compliant workflows to compete with larger incumbents.

Strategic partnerships Propose collaborative programs such as joint pilots, preferred supplier agreements, and co-marketing to build credibility and shorten the sales cycle within their biotechnology research ecosystem.